News
25 September 2026
Consistently Maintaining Halal Standards, Dexa Group Wins IHYA 2026
TANGERANG — PT Ferron Par Pharmaceuticals, a member of Dexa Group, has won the 2026 Indonesia Halal Industry Award (IHYA) from the Ministry of Industry of the Republic of Indonesia in the Large Industrial Enterprise Category, Subcategory of Best Pharmaceuticals and Traditional Medicines. This award recognizes Dexa Group’s consistency in…
24 September 2026
From Medications to Facilities, Ferron Strengthens Support for Cancer Patients
JAKARTA — Indonesia recorded 474,083 new cases and 283,299 deaths due to cancer, according to 2024 Global Cancer Observatory (GLOBOCAN) data. This situation underscores the critical role of Ferron Par Pharmaceuticals in expanding its support for cancer patients—from delivering access to medications to strengthening chemotherapy support facilities through the provision…
23 September 2026
Dharma Dexa Implements “Deal with Care” for Disaster-Affected Communities in 2026
JAKARTA — Amid a series of natural disasters impacting various regions across Indonesia throughout 2026, Dexa Group, through its Corporate Social Initiative Dharma Dexa, continues to strengthen its commitment to safeguarding health and inspiring hope for affected communities. This step marks part of Dexa Group's 57th-anniversary spirit to extend meaningful…
30 December 2025
Right to Win Through Visionary Leadership: Dexa Group Wins the Indonesia CEO Excellence Award 2025
Dexa Group has once again achieved a strategic milestone by receiving the Indonesia CEO Excellence Award 2025, organized by WartaEkonomi.co.id Research and Consulting. This award recognizes visionary leadership that consistently drives business sustainability while strengthening the pharmaceutical sector’s contribution to national health resilience. The award was presented by Muhamad Ihsan,…
10 December 2025
Karya Anak Bangsa 2025 Award Presented to Dexa Medica for Strategic Contribution to Advancing Indonesia’s Health Innovation
JAKARTA – On the occasion of the 61st National Health Day (HKN), Dexa Medica achieved a significant milestone by receiving the Karya Anak Bangsa Award from the Ministry of Health of the Republic of Indonesia, recognizing it as the pharmaceutical industry with the highest number of clinical trials for natural-based…
25 November 2025
DLBS Brings Indonesia’s Biodiversity to the Global Pharmaceutical Stage at CPHI Frankfurt 2025
As global interest in herbal medicines continues to grow, only a limited number of products are developed with rigorous scientific methods and supported by strong clinical evidence. DLBS addresses this gap through the development of Integrative Modern Natural Medicines—therapeutics based on defined bioactive fractions with clear mechanisms of action and…
3 November 2025
Dexa Medica Contributes to Supporting the Health Minister’s Target of 70 Million Indonesians Receiving Free Health Screenings by 2025
Minister of Health Budi Gunadi Sadikin has set a target for 60–70 million Indonesians to receive free health screenings by 2025. In support of this initiative, PT Dexa Medica continues to contribute through its Cek Segitiga Gratis program, which recently took place at the Car Free Day area on Boulevard…
27 October 2025
WHO and BPOM Recognize DLBS Phytopharmaceutical Innovation as a Global Benchmark in Green Pharmacy
Cikarang, October 16th, 2025 - A delegation from the World Health Organization (WHO) and Indonesia’s National Agency for Drug and Food Control (BPOM RI) visited Dexa Laboratories of Biomolecular Sciences (DLBS) to observe firsthand how Indonesia’s biodiversity is being utilized in pharmaceutical research for the development of Modern Indonesian Natural…
16 October 2025
30,000 Medicinal Plants, Only 20 Phytopharmaceuticals: Dexa Medica Strengthens Indonesia’s Role at the 16th WHO–IRCH Global Forum
Dexa Medica once again demonstrates its strong commitment as a national pharmaceutical company that plays a vital role in strengthening Indonesia’s pharmaceutical independence, particularly through the development of natural-based medicines. This commitment was reflected in its active contribution to the prestigious 16th Annual Meeting of the WHO–International Regulatory Cooperation for…
2 October 2025
Dexa Group Receives Two Prestigious Awards in One Day for Its Commitment to Halal Assurance Across All Products and Facilities
Dexa Group achieved a remarkable milestone by receiving two prestigious awards in a single day, underscoring its commitment to ensuring halal assurance across all products and facilities. The recognitions came from Indonesia’s Ministry of Industry (Kemenperin) and the Halal Inspection Body of the Institute for Food, Drug, and Cosmetic Studies…